Riskpilot← Back to searchSign inGet full accessLEANGEN LEGESENTER AS
ASActiveOrg 999255124Haakon Vii'S Gate 27, 7041 TrondheimGeneral medical practice activities · NACE 8621Est. 20126 employees
Revenue 2025
NOK 4,7M
+2% vs 2024
EBITDA margin
0.7%
-10% vs 2024
Equity ratio
7.4%
Financial strength
Net profit 2025
NOK 0
6 employees
| Revenue | NOK 4,7M | +2% |
| EBITDA | NOK 33K | -10% |
| Net profit | NOK 0 | — |
| Total assets | NOK 596K | -15% |
| Equity | NOK 44K | +0% |
| Employees | 6 | — |
Legal name
LEANGEN LEGESENTER AS
Org number
999255124
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
14. desember 2012
Share capital
NOK 30 000
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Drive legesenter, og alt som står i den forbindlese, samt å engasjere seg i lignende firma.
Address
Haakon Vii'S Gate 27, 7041 Trondheim
Phone
+4773517713
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 934 | 4 009 | 4 300 | 4 572 | 4 685 |
| Staff expenses | −979 | −1 371 | −2 032 | −2 228 | −2 290 |
| EBITDA | 0 | 20 | 17 | 37 | 33 |
| Depreciation & amort. | −0 | −0 | −0 | −14 | −14 |
| EBIT | 0 | 20 | 17 | 23 | 19 |
| Net financials | −0 | −20 | −17 | −23 | −19 |
| Profit before tax | 0 | 0 | 0 | 0 | 0 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | 0 | 0 | 0 | 0 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 249 | 532 | 726 | 699 | 596 |
| Equity | 44 | 44 | 44 | 44 | 44 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 205 | 487 | 682 | 655 | 552 |
| Total debt | 205 | 487 | 682 | 655 | 552 |
EBITDA margin
0.7%
This company
15.8%
Market median
-96% vs market
20212025
Equity ratio
7.4%
This company
38.2%
Market median
-81% vs market
20212025
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20212025
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20212025
Asset turnover
7.86×
This company
1.12×
Market median
+602% vs market
20212025
Debt / equity
12.44×
This company
0.62×
Market median
-1906% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Chairman | 2022 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 25% | 25% | 2022 | |
| Individual | 20% | 20% | 2024 | |
| Individual | 20% | 20% | 2023 | |
| Individual | 20% | 20% | 2024 | |
| Individual | 20% | 20% | 2024 | |
| Individual | 20% | 20% | 2024 | |
| Individual | 20% | 20% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LEANGEN LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ingrid Krüger-Stokke | Chairman | 0 companies |